| Name | Title | Contact Details |
|---|
Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.
National Family of Local Therapy Providers providing exceptional care & remarkable experiences. #UpstreamFamily Learn more: https://t.co/fpCrnr3vfc…
Meridian Health Plan is the largest Medicaid HMO in the State of Michigan, providing health care to over 290,000 Medicaid enrollees through a contract with the Michigan Department of Community Health (MDCH). MHP is a physician-owned, physician-managed Medicaid health plan. Its corporate headquarters are located in Detroit, Michigan. Currently, MHP operates in 67 counties. Meridian Health Plan's Michigan Medicaid HMO received an Excellent Accreditation rating from the National Committee for Quality Assurance (NCQA). Excellent is the highest possible Accreditation status from NCQA. To continuously improve the quality of care in a low resource environment
Pharos Life is a Cambridge, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MDX/MEDIREX SYSTEMS Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.